News
This was the ADR's second consecutive day of losses.
DelveInsight's BAFF- and APRIL-targeted Therapies Market Size, Target Population, Competitive Landscape & Market Forecast ...
(Reuters) -AstraZeneca said on Tuesday that U.S. regulators have approved its precision drug Datroway to treat a type of lung ...
In a follow up investigation into the multibillion dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in ...
Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, ...
Metabolism and obesity are the focus of a major research initiative by the University of Gothenburg and AstraZeneca, with the ...
In a sign of the importance of some of the imports and the damaging effect disruption could have on China's healthcare ...
A new AI-driven framework, MapDiff, enhances inverse protein folding accuracy, accelerating the design of proteins for ...
Growth is driven by the increasing prevalence of neurological disorders like Alzheimer's, Parkinson's, and schizophrenia, ...
New Report Highlights Emerging Leaders Advancing Next-generation Radiopharmaceuticals, Reshaping Cancer Care Through Targeted Innovation and Strategic Growth LONDON, June 16, 2025 /PRNewswire/ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results